Functions of p21Waf1 in norm and in stress

Molekulyarnaya Biologiya

Volumn 38, Issue 3, 2004, Pages 371-385

  Timofeev, O V ^a   Pospelova, T V ^a   Pospelov, V A ^a  

^a INSTITUTE OF CYTOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR 1; VIRUS PROTEIN; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE;

APOPTOSIS; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; DNA DAMAGE; PHOSPHORYLATION; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVIEW; SENESCENCE; STRESS; VIRUS ONCOGENE; ANIMAL; CELL CYCLE; CELL DIVISION; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEIN BINDING;

ANIMALS; CELL CYCLE; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; HUMANS; PHOSPHORYLATION; PROTEIN BINDING; STRESS;

EID: 6944244344     PISSN: 00268984     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (123)

1. McConnell B.B., Gregory F.J., Stott F.J., Hara E., Peters G. 1999. Induced expression of p16(INK4a) inhibits both CDK4- and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes. Mol. Cell. Biol. 19, 1981-1989.
2. CIP1. Mol. Cell. Biol. 16, 4673-4682.
3. Mendenhall M.D. 1993. An inhibitor of p34CDC28 protein kinase activity from Saccharomyces cerevisiae. Science. 259, 216-219.
4. Henchoz S., Chi Y., Catarin B., Herskowitz I., Deshaies R., Peter M. 1997. Phosphorylation- and ubiquitin-dependent degradation of the cyclin-dependent kinase inhibitor Far1p in budding yeast. Genes Dev. 11, 3046-3060.
5. Gu Y., Turck C.W., Morgan D.O. 1993. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature. 366, 707-710.
6. Harper J.W., Adami G.R., Wei N., Keyomarsi K., Elledge S.J. 1993. Th p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75, 805-816.
7. Xiong Y., Hannon G.J., Zhang H., Casso D., Kobayashi R., Beach D. 1993. p21 is a universal inhibitor of cyclin kinases. Nature. 366, 701-704.
8. El-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., Vogelstein B. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell. 75, 817-825.
9. Noda A., Ning Y., Venable S.F., Pereira-Smith O.M., Smith J.R. 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell. Res. 211, 90-98.
10. Dulic V., Kaumann W.K., Wilson S.J., Tlsty T.D., Lees E., Harper J.W., Elledge S.J., Reed S.I. 1994. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell. 76, 1013-1023.
11. El-Deiry W.S., Harper J.W., O'Connor P.M. et al. 1994. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54, 1169-1174.
12. Kriwacki R.W., Hengst L., Tennant L., Reed S.I., Wright P.E. 1996. Structural studies of p21Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: Conformational disorder mediates binding diversity. Proc. Natl. Acad. Sci. USA. 93, 11504-11509.
13. Lee M.H., Reynisdottir I., Massague J. 1995. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. 9, 639-649.
14. Chen J., Jackson P.K., Kirschner M.W., Dutta A. 1995. Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature. 374, 386-388.
15. Cip1. Nature. 375, 159-161.
16. Nakanishi M., Robertorye R.S., Adami G.R., Pereira-Smith O.M., Smith J.R. 1995. Identification of the active region of the DNA synthesis inhibitory gene p21Sdi1/CIP1/WAF1. EMBO J. 14, 555-563.
17. Goubin E., Ducommun B. 1995. Identification of binding domains on the p21Cip1 cyclin-dependent kinase inhibitor. Oncogene. 10, 2281-2287.
18. Harper J.W., Elledge S.J., Keyomarsi K., et al. 1995. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell. 6, 387-400.
19. Cayrol C., Knibiehler M., Ducommun B. 1998. p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells. Oncogene. 16, 311-320.
20. Park J.A., Kim K.W., Kim S.I., Lee S.K. 1998. Caspase 3 specifically cleaves p21WAF1/CIP1 in the earlier stage of apoptosis in SK-HEP-1 human hepatoma cells. Eur. J. Biochem. 257, 242-248.
21. Watanabe H., Pan Z.-Q., Schreiber-Agus N., DePinho R.A., Hurwitz J., Xiong Y. 1998. Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen. Proc. Natl. Acad. Sci. USA. 95, 1392-1397.
22. Kleman Z. 1997. PCNA: structure, functions and interactions. Oncogene. 14, 629-640.
23. Waga S., Hannon G.J., Beach D., Stillman B. 1994. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature. 369, 574-578.
24. Ogrizko V.V., Wong P., Howard B.H. 1997. WAF1 retards S-phase progression primarily by inhibition of cyclin-dependent kinases. Mol. Cell. Biol. 17, 4877-4882.
25. Zhang H., Xiong Y., Beach D. 1993. Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Oncogene. 4, 897-906.
26. Kip1 cyclin-dependent -kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature. 382, 325-331.
27. Zheleva D.I., Mclnnes C., Gavine A.L., Zhelev N.Z., Fischer P.M., Lane D.P. 2002. Highly potent p21(WAF1)-derived peptide inhibitors of CDK-mediated pRb phosphorylation: delineation and structural insight into their interactions with cyclin A. J. Pept. Res. 60, 257-270.
28. Li Y., Jenkins C.W., Nichols M.A., Xiong Y. 1994. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene. 9, 2261-2268.
29. Cip1. Genes Dev. 12, 3882-3888.
30. Adkins J.N., Lumb K.J. 2002. Stoichiometry of cyclin A-cyclin-dependent kinase 2 inhibition by p21Cip1/Waf1. Biochemistry, 39, 13925-13930.
31. Podust V.N., Podust L.M., Goubin E., Ducommun B., Hubscher U. 1995. Mechanism of inhibition of proliferating cell nuclear antigen-dependent DNA synthesis by the cyclin-dependent kinase inhibitor p21. Biochemistry. 34, 8869-8875.
32. WAF1 complexes during the cell cycle. Proc. Natl. Acad. Sci. USA. 95, 12254-12259.
33. Blain S.W., Montalvo E., Massague J. 1997. Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4. J. Biol. Chem. 272, 25863-25872.
34. Zhang H., Hannon G.J., Beach D. 1994. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev. 8, 1750-1758.
35. Soos T.J., Kiyokawa H., Yan J.S., Rubin M.S., Giordano A., DeBlasio A., Bottega S., Wong B., Mendelsohn J., Koff A. 1996. Formation of p27-CDK complexes during the human mitotic cell cycle. Cell Growth & Differentiation. 17, 135-146.
36. Sherr C., Roberts J.M. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9, 1149-1163.
37. LaBaer J., Garrett M.D., Stevenson L.F., Slingerland J.M., Sandhu C., Chou H.S., Fattaey A., Harlow E. 1997. New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11, 847-862.
38. Brugarolas J., Chandrasekaran C., Gordon J.I., Jacks T., Hannon G.J. 1995. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature. 377, 557.
39. Deng C., Zhang P., Harper J.W., Elledge S.J., Leder P. 1995. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell. 82, 675-684.
40. Cheng M., Olivier P., Diehl J.A., Fero M., Roussel M.F., Roberts J.M., Sherr C.J. 1999. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18, 1571-1583.
41. Reynisdottir I., Massague J. 1997. The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev. 11, 492-503.
42. Cip1 ubiquitination. Mol. Cell. 5, 403-410.
43. Cayrol C., Ducommun B. 1998. Interaction with cyclin-dependent kinases and PCNA modulates proteasome-dependent degradation of p21. Oncogene. 17, 2437-2444.
44. Sheaff R.J., Groudine M., Gordon M., Roberts J.M., Clurman B.E. 1997. Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev. 11, 1464-1478.
45. Vlach J., Hennecke S., Amati B. 1997. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. EMBO J. 16, 5334-5344.
46. Scott M.T., Morrice N., Ball K.L. 2000. Reversible phosphorylation at the C-terminal regulatory domain of p21Waf1/Cip1 modulates proliferating cell nuclear antigen binding. J. Biol. Chem. 275, 11529-11537.
47. Kashiwagi M., Ohba M., Watanabe H., Ishino K., Kasahara K., Sanai Y., Taya Y., Kuroki T. 2000. PKCη associates with cyclin E/cdk2/p21 complex, phosphorylates p21 and inhibits cdk2 kinase in keratinocytes. Oncogene. 19, 6334-6341.
48. Datta S.R., Brunet A., Greenberg M.E. 1999. Cellular survival: a play in three Akts. Genes Dev. 13, 2905-2927.
49. Burgering B.M., Coffer P.J. 1995. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature. 376, 599-602.
50. Zhou B.P., Liao Y., Xia W., Spohn B., Lee M.H., Hung M.C. 2001. Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat. Cell. Biol. 3, 245-252.
51. Zhou B.P., Hung M.C. 2002. Novel targets of Akt, p21(Cip1/WAF1), and MDM2. Semin. Oncol. 29 (3 Suppl 11), 62-70.
52. Rossig L., Jadidi A.S., Urbich C., Badorff C., Zeiher A.M., Dimmeler S. 2001. Akt-dependent phosphorylation of p21(Cip1) regulates PCNA binding and proliferation of endothelial cells. Mol. Cell. Biol. 21, 5644-5657.
53. Li Y., Dowbenko D., Lasky L.A. 2002. AKT/PKB Phosphorylation of p21Cip/Waf1 enhances protein stability of p21Cip/Waf1 and promotes cell survival. J. Biol. Chem. 277, 11352-11361.
54. Rössig L., Badorff C., Holzmann Y., Zeiher A.M., Dimmeler S. 2002. Glycogen synthase kinase-3 couples AKT-dependent signaling to the regulation of p21Cip1 degradation. J. Biol. Chem. 277, 9684-9689.
55. Malashicheva A.B., Kislyakova T.V., Aksenov N.D., Osipov K.A., Pospelov V.A. 2000. F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation. Oncogene. 19, 3858-3865.
56. Wang Z., Bhattacharya N., Mixter P.F., Wei W., Sedivy J., Magnuson N.S. 2002. Phosphorylation of the cell cycle inhibitor p21Cip1/WAF1 by Pim-1 kinase. Biochim. Biophys. Acta. 1593, 45-55.
57. Kim G.Y., Mercer S.E., Ewton D.Z., Van Z., Jin K., Friedman E. 2002. The stress-activated protein kinases p38 alpha and JNK1 stabilize p21(Cip1) by phosphorylation. J. Biol. Chem. 277, 29792-29802.
58. Waf1/Cip1 acts in synergy with bcl-2 to confer multidrug resistance in a camptothecin-selected human lung-cancer cell line. Int. J. Cancer. 83, 790-797.
59. Martinez L.A., Yang J., Vazquez E.S., Rodriguez-Vargas M. del C., Olive M., Hsieh J.T., Logothetis C.J., Navone N.M. 2002. p21 modulates threshold of apoptosis induced by DNA-damage and growth factor withdrawal in prostate cancer cells. Carcinogenesis. 23, 1289-1296.
60. Weiss R.H., Marshall D., Howard L., Corbacho A.M., Cheung A.T., Sawai E.T. 2003. Suppression of breast cancer growth and angiogenesis by an antisense oligodeoxynucleotide to p21(Waf1/Cip1). Cancer Lett. 189, 39-48.
61. Basu S., Kolesnick R. 1998. Stress signals for apoptosis: ceramide and c-Jun kinase. Oncogene. 17, 3277-3285.
62. Ip Y.T., Davis R.J. 1998. Signal transaction by the c-Jun N-terminal kinase (JNK) - from inflammation to development. Curr. Opin. Cell. Biol. 10, 205-219.
63. Ichijo H., Nishida E., Irie K., ten Dijke P., Saitoh M., Moriguchi T., Takagi M., Matsumoto K., Miyazono K., Gotoh Y. 1997. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science. 275, 90-94.
64. Cip1/WAF1 in monocytic differentiation. EMBO J. 18, 1223-1234.
65. Shim J., Lee H., Park J., Kim H., Choi E.J. 1996. A non-enzymatic p21 protein inhibitor of stress-activated protein kinases. Nature. 381, 804-806.
66. WAF1/Cip1: more than a break to the cell cycle? Biochim. Biophys. Acta. 1471, M43-M56.
67. Budihardjo I., Oliver H., Lutter M., Luo X., Wang X. 1999. Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol. 15, 269-290.
68. Suzuki A., Tsutomi Y., Miura M., Akahane K. 1999. Caspase 3 inactivation to suppress Fas-mediated apoptosis: identification of binding domain with p21 and ILP and inactivation machinery by p21. Oncogene. 18, 1239-1244.
69. Suzuki A., Kawano H., Hayashida M., Hayasaki Y., Tsutomi Y., Akahane K. 2000. Procaspase 3/p21 complex formation to resist fas-mediated cell death is initiated as a result of the phosphorylation of p21 by protein kinase A. Cell Death Differ. 7, 721-728.
70. Cip1/Waf1 by Caspases Is an Early Event during DNA Damage-induced Apoptosis. J. Biol. Chem. 273, 19207-19212.
71. Zhang Y., Fujita N., Tsuruo T. 1999b. Caspase-mediated cleavage of p21Waf1/Cip1 converts cancer cells from growth arrest to undergoing apoptosis. Oncogene. 18, 1131-1138.
72. Duttaroy A., Qian J.F., Smith J.S., Wang E. 1997. Upregulated P21CIP1 expression is part of the regulation quantitatively controlling serum deprivation-induced apoptosis. J. Cell. Biochem. 64, 434-446.
73. Aerawal S., Agrawal M.L., Chatterjee-Kishore M., Stark G.R., Chisolm G.M. 2002. Stat1-Dependent, p53-Independent Expression of p21waf1 modulates Oxysterol-Induced Apoptosis. Mol. Cell. Biol. 22, 1981-1992.
74. (WAF1/SDII/CIP1) Gene Transfer Induces Apoptosis of Human Cervical Cancer Cell Lines. J. Virol. 73, 4983-4990.
75. Nozell S., Chen X. 2002. p21B, a variant of p21Waf1/Cip1, is induced by the p53 family. Oncogene. 21, 1285-1294.
76. Cip1 and is involved in the regulation of its nuclear localization. J. Biol Chem. 274, 24445-24448.
77. Delavaine L., La Thangue N.B. 1999. Control of E2F activity by p21Waf1/Cip1. Oncogene. 18, 5381-5392.
78. cip1/waf1/sdi1 in DNA Replication and Transcription. J. Biol. Chem. 275, 10477-10483.
79. Di Cunto F., Topley G., Calautti E., Hsiao J., Ong L., Seth P.K., Dotto G.P. 1998. Inhibitory function of p21Cip1/WAF1 in differentiation of primary mouse keratinocytes independent of cell cycle control. Science. 280, 1069-1072.
80. Peng C.Y., Graves P.R., Thoma R.S., Wu Z., Shaw A.S., Piwnica-Worms H. 1997. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science. 277, 1501-1505.
81. Solomon D.L., Lee T., Kirschner M.W. 1992. Role of phosphorylation in p34cdc2 activation: identification of an activating kinase. Mol. Biol. Cell. 3, 13-27.
82. Papathanasiou M.A., Kerr N.C., Robbins J.H., McBride O.W., Alama I. Jr., Barrett S.F., Hickson I.D., Fornace Jr. 1991. Induction by ionizing radiation of the gadd45 gene in cultured human cells: lack of mediation by protein kinase C. Mol. Cell. Biol. 11, 1009-1016.
83. 2 arrest after DNA damage. Science. 282, 1497-1501.
84. Kearsey J.M., Coates P.J., Prescott A.R., Warbrick E., Hall P.A. 1995. Gadd45 is a nuclear cell cycle regulated protein which interacts with p21Cip1. Oncogene. 11, 1675-1683.
85. Vairapandi M., Balliet A.G., Fornace A.J.Jr., Hoffman B., Lieberman D.A. 1996. The differentiation primary response gene MyD118, related to GADD45, encodes for a nuclear protein which interacts with PCNA and p21WAF1/CIP1. Oncogene. 12, 2579-2594.
86. 2/M Checkpoint. J. Biol. Chem. 275, 36892-36898.
87. Kovalsky O., Lung F.D., Roller P.P., Fornace A.J.Jr. 2001. Oligomerization of human Gadd45a protein. J. Biol. Chem. 276, 39330-39339.
88. Cip1/WAF1. Proc. Natl. Acad. Sci. USA. 99, 5430-5435.
89. Cip1 on Cyclin E-Cyclin-dependent kinase 2 activity. J. Biol. Chem. 274, 33161-33165.
90. Cip1-binding protein that cooperatively enhances p21-dependent inhibitory activity toward CDK2 kinase. J. Biol. Chem. 275, 31145-31154.
91. Mitsui K., Matsumoto A., Ohtsuka S., Ohtsubo M., Yoshimura A. 1999. Cloning and characterization of a novel p21(Cip1/Waf1)-interacting zinc finger protein, ciz1. Biochem. Biophys. Res. Commun. 264, 457-464.
92. Funk J.O., Waga S., Harry J.B., Espling E., Stillman B., Galloway D.A. 1997. Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. Genes Dev. 11, 2090-2100.
93. Westbrook T.F., Nguyen D.X., Thrash B.R., McCance D.J. 2002. E7 abolishes raf-induced arrest via mislocalization of p21(Cip1). Mol. Cell. Biol. 22, 7041-7052.
94. Porras A., Gaillard S., Rundell K. 1999. The simian virus 40 small-t and large-T antigens jointly regulate cell cycle reentry in human fibroblasts. J. Virol. 73, 3102-3107.
95. Decesse J.T., Medjkane S., Datto M.B., Cremisi C.E. 2001. RB regulates transcription of the p21/WAF1/CIP1 gene. Oncogene. 20, 962-971.
96. Somasundaram R., El-Deiry W.S. 1997. Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region. Oncogene. 14, 1047-1057.
97. Steegenga W.T., van Laar T., Riteco N., Mandarino A., Shvarts A., van der Eb A., Jochemsen A.G. 1996. Adenovirus E1A proteins inhibit activation of transcription by p53. Mol. Cell. Biol. 16, 2101-2109.
98. Missero C., Calautti E., Eckner R., Chin J., Tsai L.H., Livingston D.M., Dotto G.P. 1995. Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc. Natl. Acad. Sci. USA. 92, 5451-5455.
99. Bulavin D.V., Tararova N.D., Aksenov N.D., Pospelov V.A., Pospelova T.V. 1999. Deregulation of p53/p21Cip1/waf1 pathway contributes to polyploidy and apoptosis of E1A + cHa-ras transformed cells after γ-irradiation. Oncogene. 18, 5611-5619.
100. CIP1/WAF1. J Gen. Virol. 80, 381-390.
101. Chattopadhyay D., Ghosh M.K., Mal A., Harter M.L. 2001. Inactivation of p21 by E1A leads to the induction of apoptosis in DNA-damaged cells. J. Virol. 75, 9844-9856.
102. Frisch S.M., Mymryk J.S. 2002. Adenovirus-5 E1A: paradox and paradigm. Nature Rev. Mol. Cell Biol. 3, 441-452.
103. Mal A., Chattopadhyay D., Ghosh M.K., Poon R.Y., Hunter T., Harter M.L. 2000. p21 and retinoblastoma protein control the absence of DNA replication in terminally differentiated muscle cells. Cell Biol. 149, 281-292.
104. Mal A., Piotrkowski A., Harter M.L. 1996. Cyclin-dependent kinases phosphorylate the adenovirus E1A protein, enhancing its ability to bind pRb and disrupt pRb-E2F complexes. J. Virol. 70, 2911-2921.
105. Nomura H., Sawada Y., Ohtaki S. 1998. Interaction of p27 with E1A and its effect on CDK kinase activity. Biochem. Biophys. Res. Commun. 248, 228-234.
106. Perez-Roger I., Solomon D.L., Sewing A., Land H. 1997. Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27(Kip1) binding to newly formed complexes. Oncogene. 14, 2373-2381.
107. Vlach J., Hennecke S., Alevizopoulos K., Conti D., Amati B. 1996. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc. EMBO J. 15, 6595-6604.
108. Malumbres M.B.M. 2001. To cyle or not to cycle: A critical decision in cancer. Nature Rev. Cancer. 1, 222-231.
109. Egan S.E., Weinberg R.A. 1993. The pathway to signal achievement. Nature. 365, 781-783.
110. Voitek A.B., Der C.J. 1998. Increasing Complexity of the Ras Signaling Pathway. J. Biol. Chem. 273, 19925-19928.
111. 1-phase progression. Genes Dev. 13, 1501-1512.
112. Tamrakar S., Rubin E., Ludlow J.W. 2000. Role of pRB dephosphorylation in cell cycle regulation. Front. Biosc. 5, d121-d137.
113. Diehl J.A., Cheng M., Roussel M.F., Sherr C. 1998. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12, 3499-3511.
114. Gregory D.J., Garcia-Wilson E., Poole J.C., Snowden A.W., Roninson I.E., Perkins N.D. 2002. Induction of Transcription through the p300 CRD1 Motif by p21(WAF1/CIP1) Is Core Promoter Specific and Cyclin Dependent Kinase Independent. Cell Cycle. 1, 343-350.
115. Perkins N.D. 2002. Not just a CDK inhibitor: regulation of transcription by p21(WAF1/CIP1/SDI1). Cell Cycle. 1, 39-41.
116. Zhu H., Chang B.D., Uchiumi T., Roninson I.B. 2002. Identification of promoter elements responsible for transcriptional inhibition of polo-like kinase 1 and topoisomerase IIalpha genes by p21(WAFl/CIP1/SDI1). Cell Cycle. 1, 59-66.
117. Winters Z.E. 2002. P53 pathways involving G2 checkpoint regulators and the role of their subcellular localisation. J. R Coll. Surg. Edinb. 47, 591-598.
118. Nargi J.L., Ratan R.R., Griffin D.E. 1999. p53-independent inhibition of proliferation and p21(WAF1/Cip1)-modulated induction of cell death by the antioxidants N-acetylcysteine and vitamin E. Neoplasi. 1, 544-556.
119. Macip S., Igarashi M., Fang L., Chen A., Pan Z.Q., Lee S.W., Aaronson S.A. 2002. Inhibition of p21-mediated ROS accumulation can rescue p21-induced senescence. EMBO J. 21, 2180-2188.
120. Helt C.E., Rancourt R.C., Staversky R.J., O'Reilly M.A. 2001. p53-dependent induction of p21(Cip1/WAF1/Sdi1) protects against oxygen-induced toxicity. Toxicol. Sci. 63, 214-222.
121. Xie S., Wang Q., Luo L., Ruan Q., Liu T., Jhanwar-Uniyal M., Darzynkiewicz Z., Traganos F., Dai W. 2002. Proteasome-dependent downregulation of p21(Waf1/Cip1) induced by reactive oxygen species. J. Interferon Cytokine Res. 22, 957-963.